An overview of chronic severe asthma

Internal Medicine Journal

Volumn 38, Issue 3, 2008, Pages 190-198

  Polosa, R ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Chronic severe asthma; Differential diagnosis; Pharmacotherapy; Steroid refractoriness

Indexed keywords

AZATHIOPRINE; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYCLOSPORIN A; ETANERCEPT; GOLD; IMMUNOGLOBULIN; METHOTREXATE; OMALIZUMAB; PREDNISONE; TROLEANDOMYCIN;

ABDOMINAL PAIN; ADRENAL INSUFFICIENCY; CATARACT; CHEST TIGHTNESS; CHRONIC DISEASE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DIABETES MELLITUS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIARRHEA; DISEASE EXACERBATION; DRUG ERUPTION; DRUG MEGADOSE; DRUG MONITORING; DYSPHAGIA; DYSPNEA; FLU LIKE SYNDROME; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HEART PALPITATION; HOARSENESS; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRICHOSIS; INFECTION SENSITIVITY; INJECTION SITE RASH; INJECTION SITE REACTION; LIVER FUNCTION TEST; LOADING DRUG DOSE; LUNG FUNCTION TEST; MOON FACE; MOUTH ULCER; MYOPATHY; NAUSEA; OSTEOPOROSIS; PARESTHESIA; PATIENT MONITORING; PHARYNGITIS; PRIORITY JOURNAL; REVIEW; RHINOSINUSITIS; SEVERE PERSISTENT ASTHMA; SEX DIFFERENCE; SIDE EFFECT; SKIN MANIFESTATION; SPIROMETRY; STOMATITIS; TACHYCARDIA; THERAPY EFFECT; THRUSH; TREATMENT RESPONSE; TREMOR; VOMITING; WEIGHT GAIN; WHEEZING;

ADRENERGIC BETA-AGONISTS; ASTHMA; CHRONIC DISEASE; GLUCOCORTICOIDS; HUMANS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 39449103632     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01547.x     Document Type: Review

References (40)

1. Akinbami LJ, Schoendorf KC. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics 2002 110 : 315 22.
2. Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J 1998 12 : 1209 18.
3. Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F et al. Asthma severity and medical resource utilization. Eur Respir J 2004 23 : 723 9.
4. Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med 2005 172 : 149 60.
5. Holgate ST, Polosa R. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006 368 : 780 93.
6. Harrison BD. Difficult asthma in adults: recognition and approaches to management. Intern Med J 2005 35 : 543 7.
7. Cochrane GM, Horne R, Chanez P. Compliance in asthma. Respir Med 1999 93 : 763 9.
8. Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L et al. National Heart, Lung, Blood Institute's Severe Asthma Research Program. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 2007 119 : 405 13.
9. Gotway MB, Reddy GP, Webb WR, Elicker BM, Leung JW. High-resolution CT of the lung: patterns of disease and differential diagnoses. Radiol Clin North Am 2005 43 : 513 42, viii.
10. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF et al. Allergy Research Group of the National Heart and Lung Institute. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003 22 : 478 83.
11. Heaney LG, Conway E, Kelly C, Johnston BT, English C, Stevenson M et al. Predictors of therapy resistant asthma: outcome of a systematic evaluation protocol. Thorax 2003 58 : 561 6.
12. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002 110 : 685 92.
13. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet 2003 361 : 587 94.
14. ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005 26 : 812 18.
15. Mascia K, Haselkorn T, Deniz YM, Miller DP, Bleecker ER, Borish L. TENOR Study Group. Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 2005 116 : 970 75.
16. Bachert C, Patou J, Van Cauwenberge P. The role of sinus disease in asthma. Curr Opin Allergy Clin Immunol 2006 6 : 29 36.
17. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur Respir J 2004 24 : 822 33.
18. Campbell DA, Yellowlees PM, McLennan G, Coates JR, Frith PA, Gluyas PA et al. Psychiatric and medical features of near fatal asthma. Thorax 1995 50 : 254 9.
19. Miles JF, Garden GM, Tunnicliffe WS, Cayton RM, Ayres JG. Psychological morbidity and coping skills in patients with brittle and non-brittle asthma: a case-control study. Clin Exp Allergy 1997 27 : 1151 9.
20. Global Initiative for Asthma. Global strategy for asthma management and prevention. A six part management program. Bethesda : NIH Publication Number 02-3659 Cited 2006 Nov 9 Available from URL : http://www.ginasthma.org
21. Gibson P, Powell H, Ducharme FJ. Long-acting beta2-agonists as an inhaled corticosteroid sparing agent for chronic asthma in adults and children. Cochrane Database Syst Rev 2005 4 : CD 005076.
22. Marin MG. Low-dose methotrexate spares steroid usage in steroid-dependent asthmatic patients: a meta-analysis. Chest 1997 112 : 29 33.
23. Aaron SD, Dales RE, Pham B. Management of steroid-dependent asthma with methotrexate: a meta-analysis of randomized clinical trials. Respir Med 1998 92 : 1059 65.
24. Davies H, Olson L, Gibson P. Methotrexate as a steroid-sparing agent for asthma in adults. Cochrane Database Syst Rev 2000 2 CD 000391.
25. Mullarkey MF, Lammert JK, Blumenstein BA. Long-term methotrexate treatment in corticosteroid-dependent asthma. Ann Intern Med 1990 112 : 577 81.
26. Shiner RJ, Katz I, Shulimzon T, Silkoff P, Benzaray S. Methotrexate in steroid-dependent asthma: long-term results. Allergy 1994 49 : 565 8.
27. Comet R, Domingo C, Larrosa M, Moron A, Rue M, Amengual MJ et al. Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double-blind, randomized, placebo-controlled study. Respir Med 2006 100 : 411 19.
28. Bernstein IL, Bernstein DI, Dubb JW, Faiferman I, Wallin B. A placebo controlled multicenter study of auranofin in the treatment of patients with corticosteroid-dependent asthma. Auranofin Multicenter Drug Trial. J Allergy Clin Immunol 1996 98 : 317 24.
29. Alexander AG, Barnes NC, Kay AB. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 1992 339 : 324 8.
30. Lock SH, Kay AB, Barnes NC. Double-blind, placebocontrolled study of cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am J Respir Crit Care Med 1996 153 : 509 14.
31. Nizankowska E, Soja J, Pinis G, Bochenek G, Sladek K, Domagala B et al. Treatment of steroid dependent bronchial asthma with cyclosporin. Eur Respir J 1995 8 : 1091 9.
32. Salmun LM, Barlan I, Wolf HM, Eibl M, Twarog FJ, Geha RS et al. Effect of intravenous immunoglobulin on steroid consumption in patients with severe asthma: a double-blind, placebo-controlled, randomized trial. J Allergy Clin Immunol 1999 103 : 810 15.
33. Kishiyama JL, Valacer D, Cunningham-Rundles C, Sperber K, Richmond GW, Abramson S et al. A multi-center, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma. Clin Immunol 1999 91 : 126 33.
34. Nelson HS, Hamilos DL, Corsello PR, Levesque NV, Buchmeier AD, Bucher BL. A double-blind study of troleandomycin and methylprednisolone in asthmatic subjects who require daily corticosteroids. Am Rev Respir Dis 1993 147 : 398 404.
35. Dean T, Dewey A, Bara A, Lasserson TJ, Walters EH. Azathioprine as an oral corticosteroid sparing agent for asthma. Cochrane Database Syst Rev 2004 1 CD 003270.
36. Howarth PH, Babu KS, Arshad HS, Lau L, Buckley M, McConnell W et al. Tumour necrosis factor (TNFalfa) as a novel therapeutic target in symptomatic corticosteroid dependent asthma. Thorax 2005 60 : 1012 18.
37. Berry MA, Hargadon B, Shelley M, Parker D, Shaw DE, Green RH et al. Evidence of a role of tumor necrosis factor alfa in refractory asthma. N Engl J Med 2006 354 : 697 708.
38. Erin EM, Leaker BR, Nicholson GC, Tan AJ, Green LM, Neighbour H et al. The effects of a monoclonal antibody directed against tumour necrosis factor-alfa (TNF-alfa) in asthma. Am J Respir Crit Care Med 2006 174 : 753 62.
39. Niebauer K, Dewilde S, Fox-Rushby J, Revicki DA. Impact of omalizumab on quality-of-life outcomes in patients with moderate-to-severe allergic asthma. Ann Allergy Asthma Immunol 2006 96 : 316 26.
40. Humbert M, Beasley R, Ayres J, Slavin R, Hebert J, Bousquet J et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 2005 60 : 309 16.